0YAY Stock Overview Provides assisted reproduction products. More details
Rewards Risk Analysis No risks detected for 0YAY from our risk checks.
See All Risk Checks Capture your thoughts, links and company narrative
Vitrolife AB (publ) Competitors Price History & Performance
Summary of share price highs, lows and changes for Vitrolife Historical stock prices Current Share Price SEK 214.80 52 Week High SEK 265.80 52 Week Low SEK 157.10 Beta 1.8 1 Month Change -3.42% 3 Month Change -14.97% 1 Year Change 8.95% 3 Year Change -61.12% 5 Year Change 7.99% Change since IPO 3,701.77%
Recent News & Updates
Vitrolife AB (Publ) Announces Chief Financial Officer Changes Dec 03
Vitrolife AB (publ) to Report Fiscal Year 2024 Final Results on Mar 27, 2025 Nov 16
Vitrolife AB (publ) to Report Q4, 2025 Results on Jan 29, 2026 Oct 27
Third quarter 2024 earnings released: EPS: kr0.86 (vs kr0.90 in 3Q 2023) Oct 24
Vitrolife AB (Publ) Announces Election Committee Appointments Oct 04
Now 23% overvalued after recent price rise Aug 30 See more updates
Vitrolife AB (Publ) Announces Chief Financial Officer Changes Dec 03
Vitrolife AB (publ) to Report Fiscal Year 2024 Final Results on Mar 27, 2025 Nov 16
Vitrolife AB (publ) to Report Q4, 2025 Results on Jan 29, 2026 Oct 27
Third quarter 2024 earnings released: EPS: kr0.86 (vs kr0.90 in 3Q 2023) Oct 24
Vitrolife AB (Publ) Announces Election Committee Appointments Oct 04
Now 23% overvalued after recent price rise Aug 30
Now 21% overvalued after recent price rise Jul 24 Vitrolife AB (publ) to Report Q3, 2025 Results on Oct 29, 2025
Second quarter 2024 earnings released: EPS: kr1.06 (vs kr0.78 in 2Q 2023) Jul 18
Vitrolife AB (publ) (OM:VITR) acquired Stb Zorg B.V. May 23
Director recently bought kr1.6m worth of stock May 17 Vitrolife AB (publ) (OM:VITR) signed an agreement to acquire Stb Zorg B.V. for €18 million. May 03
Vitrolife AB (Publ) Approves Dividend for the Financial Year 2023 Apr 27
Upcoming dividend of kr1.00 per share Apr 22
Now 20% undervalued Apr 19
First quarter 2024 earnings released: EPS: kr0.85 (vs kr0.74 in 1Q 2023) Apr 18
Dividend increased to kr1.00 Apr 06
Full year 2023 earnings released: kr28.44 loss per share (vs kr2.91 profit in FY 2022) Feb 02 Vitrolife AB (publ) to Report Fiscal Year 2023 Final Results on Mar 27, 2024 Vitrolife AB (Publ) Reports Non-Cash Impairment for the Fourth Quarter of 2023 Jan 24
Investor sentiment improves as stock rises 15% Nov 03
Third quarter 2023 earnings released: EPS: kr0.90 (vs kr0.80 in 3Q 2022) Oct 28
Vitrolife AB (publ) Announces Election Committee Appointments Oct 06
Vitrolife AB (publ) Announces Resignation of Maria Forss as Senior Vice President Aug 24
Insufficient new directors Aug 03
Vitrolife AB Announces Board Changes Aug 01
Chief Financial Officer recently bought kr335k worth of stock Jul 28
Investor sentiment deteriorates as stock falls 21% Jul 21
New minor risk - Share price stability Jul 14
Second quarter 2023 earnings released: EPS: kr0.78 (vs kr0.96 in 2Q 2022) Jul 14 Vitrolife AB (publ) to Report Q3, 2024 Results on Oct 24, 2024
Chief Financial Officer recently bought kr535k worth of stock Apr 28
Upcoming dividend of kr0.85 per share at 0.4% yield Apr 21
Full year 2022 earnings released: EPS: kr2.91 (vs kr2.98 in FY 2021) Apr 02
Full year 2022 earnings released: EPS: kr2.91 (vs kr2.98 in FY 2021) Feb 04 Vitrolife AB (publ) Proposes Dividend for 2022
Vitrolife AB (publ) Announces Executive Changes Feb 01
Second quarter 2022 earnings released: EPS: kr0.96 (vs kr0.79 in 2Q 2021) Oct 27
Investor sentiment improved over the past week Oct 27 Vitrolife AB (publ) to Report First Half, 2023 Results on Jul 14, 2023
Vitrolife AB (publ) Announces Election Committee Appointments Oct 11
Now 29% undervalued after recent price drop Sep 27
Investor sentiment deteriorated over the past week Sep 22
Vitrolife AB (Publ) Announces Retirement of Thomas Axelsson as CEO Sep 13
Second quarter 2022 earnings released: EPS: kr0.96 (vs kr0.79 in 2Q 2021) Jul 17
Vitrolife AB (publ), Annual General Meeting, Apr 27, 2023 Jul 08
Chief Financial Officer recently bought kr496k worth of stock May 04
First quarter 2022 earnings released: EPS: kr0.61 (vs kr1.09 in 1Q 2021) Apr 27
First quarter 2022 earnings released: EPS: kr0.61 (vs kr1.09 in 1Q 2021) Apr 23
Upcoming dividend of kr0.80 per share Apr 21
Vitrolife AB (Publ) Proposes Dividend Mar 29
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Feb 17
Vitrolife AB (Publ) Proposes Dividend Feb 16
Third quarter 2021 earnings released: EPS kr0.89 (vs kr0.81 in 3Q 2020) Oct 30
Second quarter 2021 earnings released: EPS kr0.79 (vs kr0.11 in 2Q 2020) Jul 16
Vitrolife AB (publ) Approves Dividend for the Financial Year 2020 Apr 29
First quarter 2021 earnings released: EPS kr1.09 (vs kr0.73 in 1Q 2020) Apr 24
Upcoming dividend of kr0.80 per share Apr 24
Full year 2020 earnings released: EPS kr2.64 (vs kr3.53 in FY 2019) Apr 02
Full year 2020 earnings released: EPS kr2.64 (vs kr3.53 in FY 2019) Feb 11
Revenue misses expectations Feb 11
New 90-day high: kr237 Feb 03
Vitrolife AB (publ) to Report Fiscal Year 2020 Results on Feb 10, 2021 Jan 22
New 90-day low: kr209 Nov 12
Revenue beats expectations Nov 07
Third quarter 2020 earnings released: EPS kr0.81 Nov 07
Vitrolife AB (publ) to Report Fiscal Year 2020 Results on Mar 30, 2021 Nov 07 Vitrolife AB (publ) to Report Q1, 2021 Results on Apr 22, 2021
Vitrolife AB (Publ) Announces Appointment of Election Committee Oct 29
New 90-day high - kr246 Sep 15
New 90-day high - kr225 Aug 06 Shareholder Returns 0YAY GB Biotechs GB Market 7D 0.6% -1.0% -0.6% 1Y 8.9% -24.1% 3.1%
See full shareholder returns
Return vs Industry: 0YAY exceeded the UK Biotechs industry which returned -24.1% over the past year.
Return vs Market: 0YAY exceeded the UK Market which returned 3.1% over the past year.
Price Volatility Is 0YAY's price volatile compared to industry and market? 0YAY volatility 0YAY Average Weekly Movement 4.7% Biotechs Industry Average Movement 7.0% Market Average Movement 4.8% 10% most volatile stocks in GB Market 10.6% 10% least volatile stocks in GB Market 2.6%
Stable Share Price: 0YAY has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0YAY's weekly volatility (5%) has been stable over the past year.
About the Company Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems.
Show more Vitrolife AB (publ) Fundamentals Summary How do Vitrolife's earnings and revenue compare to its market cap? 0YAY fundamental statistics Market cap SEK 29.19b Earnings (TTM ) -SEK 3.80b Revenue (TTM ) SEK 3.56b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 0YAY income statement (TTM ) Revenue SEK 3.56b Cost of Revenue SEK 1.49b Gross Profit SEK 2.07b Other Expenses SEK 5.87b Earnings -SEK 3.80b
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 30, 2025
Earnings per share (EPS) -28.10 Gross Margin 58.17% Net Profit Margin -107.03% Debt/Equity Ratio 14.6%
How did 0YAY perform over the long term?
See historical performance and comparison Dividends
0.5% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/26 03:59 End of Day Share Price 2024/12/23 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Vitrolife AB (publ) is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Erik Cassel ABG Sundal Collier Sponsored null null ABG Sundal Collier Sponsored Kallum Titchmarsh BofA Global Research
Show 8 more analysts 
